FARRIS BURNS: Open Payments
NPI 1942750187 · FULTON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,327 in 87 payments from 17 companies in 2025. Trend: 2023 $1,153 · 2024 $1,203 · 2025 $1,327
Food & beverage: $1,327
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $215 |
| Amgen Inc. | 12 | $179 |
| Novo Nordisk Inc | 11 | $173 |
| PFIZER INC. | 11 | $172 |
| Otsuka America Pharmaceutical, Inc. | 7 | $151 |
| Lilly USA, LLC | 6 | $103 |
| Xeris Pharmaceuticals, Inc. | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $43 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
Products named: REXULTI, VRAYLAR, NURTEC ODT, MOUNJARO, OTEZLA, EVENITY, Wegovy, KEVEYIS.
Industry payments across MS — which companies pay providers there.
